相似文献
1
Genome watch: overtake in reverse gear.
Nat Rev Microbiol. 2008 May;6(5):334-5. doi: 10.1038/nrmicro1898.
2
Genome-based vaccine development: a short cut for the future.
Hum Vaccin. 2008 May-Jun;4(3):184-8. doi: 10.4161/hv.4.3.6313. Epub 2010 May 15.
3
Genome-based vaccine development: a short cut for the future.
Adv Exp Med Biol. 2009;655:81-9. doi: 10.1007/978-1-4419-1132-2_8.
4
Genome-based vaccines.
Int J Med Microbiol. 2004 Oct;294(5):295-301. doi: 10.1016/j.ijmm.2004.07.008.
5
Bioinformatics: how it is being used to identify bacterial vaccine candidates.
Expert Rev Vaccines. 2003 Jun;2(3):417-36. doi: 10.1586/14760584.2.3.417.
6
Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
Emerg Infect Dis. 2018 Apr;24(4):673-682. doi: 10.3201/eid2404.171480.
7
Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples.
Mol Cell Probes. 1999 Feb;13(1):49-60. doi: 10.1006/mcpr.1998.0218.
8
Microbiology. A furtive pathogen revealed.
Science. 2000 Mar 10;287(5459):1767-8. doi: 10.1126/science.287.5459.1767.
9
Real-time PCR detection of five prevalent bacteria causing acute meningitis.
APMIS. 2009 Nov;117(11):856-60. doi: 10.1111/j.1600-0463.2009.02539.x.
10
Towards a universal group B Streptococcus vaccine using multistrain genome analysis.
Expert Rev Vaccines. 2006 Oct;5(5):687-94. doi: 10.1586/14760584.5.5.687.
引用本文的文献
1
Advances in bioinformatics and multi-omics integration: transforming viral infectious disease research in veterinary medicine.
Virol J. 2025 Jan 31;22(1):22. doi: 10.1186/s12985-025-02640-x.
2
Comparative Genome Analysis of Piscine : Virulence-Associated Metabolic Pathways.
Microorganisms. 2024 Dec 6;12(12):2518. doi: 10.3390/microorganisms12122518.
3
Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines.
Pharmaceutics. 2022 Dec 31;15(1):152. doi: 10.3390/pharmaceutics15010152.
4
The use of genomics in microbial vaccine development.
Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15.
本文引用的文献
1
Pathogenomics: an updated European Research Agenda.
Infect Genet Evol. 2008 May;8(3):386-93. doi: 10.1016/j.meegid.2008.01.005. Epub 2008 Jan 18.
2
Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates.
Genome Res. 2008 Jan;18(1):161-71. doi: 10.1101/gr.7020108. Epub 2007 Nov 21.
3
The microbial pan-genome.
Curr Opin Genet Dev. 2005 Dec;15(6):589-94. doi: 10.1016/j.gde.2005.09.006. Epub 2005 Sep 26.
4
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome".
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13950-5. doi: 10.1073/pnas.0506758102. Epub 2005 Sep 19.
5
Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Science. 2005 Jul 1;309(5731):148-50. doi: 10.1126/science.1109869.
6
Reverse vaccinology and genomics.
Science. 2003 Oct 24;302(5645):602. doi: 10.1126/science.1092329.
7
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18.
Nature. 2001 Oct 25;413(6858):848-52. doi: 10.1038/35101607.
8
Reverse vaccinology.
Curr Opin Microbiol. 2000 Oct;3(5):445-50. doi: 10.1016/s1369-5274(00)00119-3.
9
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
Science. 2000 Mar 10;287(5459):1816-20. doi: 10.1126/science.287.5459.1816.
Zotero 插件